Other Species / Isoforms
  axin 2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S70-p
GEPEGRAsPDsPLTR
0 4
axin 2 (human) GEPEGRAsPDsPLTR S70-p
axin 2 (mouse) GEPEGRASPDSPLTR S70
S73-p
EGRAsPDsPLTRWTk
0 1
axin 2 (human) EGRAsPDsPLTRWTk S73-p
axin 2 (mouse) EGRASPDSPLTRWTK S73
K80-ub
sPLTRWTkSLHSLLG
0 1
axin 2 (human) sPLTRWTkSLHSLLG K80-ub
axin 2 (mouse) SPLTRWTKSLHSLLG K80
S146-p
IENNSIVsKQLKPAT
0 1
axin 2 (human) IENNSIVsKQLKPAT S146-p
axin 2 (mouse) IENNSVVSKQLKPAT S146
S217
MSNGGLGSLKVVCGY
0 1
axin 2 (human) MSNGGLGSLKVVCGY S217
axin 2 (mouse) MSNGGLGsLKVLCGY S217-p
S244-p
ADFKCKLsPtVVGLS
0 2
axin 2 (human) ADFKCKLsPtVVGLS S244-p
axin 2 (mouse) ADLKCKLsPTVVGLS S244-p
T246-p
FKCKLsPtVVGLSSK
0 1
axin 2 (human) FKCKLsPtVVGLSSK T246-p
axin 2 (mouse) LKCKLsPTVVGLSSK T246
S311-p
SDALTDDsMSMTDSS
Upstream
Downstream
1 0
Effects on Modified Protein
  • phosphorylation
  • protein degradation
  • protein stabilization
Effects on Biological Processes:
  • carcinogenesis, inhibited
  • cell cycle regulation
  • cell growth, inhibited
  • signaling pathway regulation
  • transcription, inhibited
Kinase, in vitro:
  • PLK1 (human)
Putative in vivo kinases:
  • PLK1 (human)
Treatment
  • BI2536
  • nocodazole
  • siRNA
axin 2 (human) SDALTDDsMSMTDSS S311-p
axin 2 (mouse) SDALTDDSMSMTDSS S311
S348-p
VKANGQVsLPHFPRT
0 1
axin 2 (human) VKANGQVsLPHFPRT S348-p
axin 2 (mouse) VKANGQVSLPHFPRT S348
T449-p
HLSRVLKtPGCQsPG
0 2
axin 2 (human) HLSRVLKtPGCQsPG T449-p
axin 2 (mouse) HLSRVLKTPGCQSPG T449
S454-p
LKtPGCQsPGVGRYs
0 2
axin 2 (human) LKtPGCQsPGVGRYs S454-p
axin 2 (mouse) LKTPGCQSPGVGRyS S454
Y460
QsPGVGRYsPRSRSP
0 1
axin 2 (human) QsPGVGRYsPRSRSP Y460
axin 2 (mouse) QSPGVGRySPRsRSP Y460-p
S461-p
sPGVGRYsPRSRSPD
0 1
axin 2 (human) sPGVGRYsPRSRSPD S461-p
axin 2 (mouse) SPGVGRySPRsRSPD S461
S464
VGRYsPRSRSPDHHH
0 1
axin 2 (human) VGRYsPRSRSPDHHH S464
axin 2 (mouse) VGRySPRsRSPDHHH S464-p
S493-p
KLPPAAAsPGACPLL
0 1
axin 2 (human) KLPPAAAsPGACPLL S493-p
axin 2 (mouse) gap -
K528-ub
HHAVPKTkEEIEAEA
0 1
axin 2 (human) HHAVPKTkEEIEAEA K528-ub
axin 2 (mouse) HHAVPKTKEEIEAEA K526
Y549-p
FCPGGSEyYCYSKCK
0 1
axin 2 (human) FCPGGSEyYCYSKCK Y549-p
axin 2 (mouse) LCPGGTDYYCYSKCK Y547
S630-p
MLESERQsKPkPHSA
0 1
axin 2 (human) MLESERQsKPkPHSA S630-p
axin 2 (mouse) MLESERQSKSKPHSA S628
K633-ac
SERQsKPkPHSAQst
0 1
axin 2 (human) SERQsKPkPHSAQst K633-ac
axin 2 (mouse) SERQSKSKPHSAQSI K631
S639-p
PkPHSAQstKKAYPL
0 1
axin 2 (human) PkPHSAQstKKAYPL S639-p
axin 2 (mouse) SKPHSAQSIRKSYPL S637
T640-p
kPHSAQstKKAYPLE
0 2
axin 2 (human) kPHSAQstKKAYPLE T640-p
axin 2 (mouse) KPHSAQSIRKSYPLE I638
K792-ac
SLTLGHFkEQLSkKG
0 1
axin 2 (human) SLTLGHFkEQLSkKG K792-ac
axin 2 (mouse) SLTLGHFKEQLSKKG K789
K797-ac
HFkEQLSkKGNYRYY
0 1
axin 2 (human) HFkEQLSkKGNYRYY K797-ac
axin 2 (mouse) HFKEQLSKKGNYRYY K794
K806-ac
GNYRYYFkKASDEFA
0 1
axin 2 (human) GNYRYYFkKASDEFA K806-ac
axin 2 (mouse) GNYRYYFKKASDEFA K803
K838-ub
YEGRILGkVERID__
0 1
axin 2 (human) YEGRILGkVERID__ K838-ub
axin 2 (mouse) YEGRILGKVERID__ K835